Skip to Content

Ondansetron Hydrochloride Injection

Last Updated: June 6, 2018
Status: Current

Products Affected - Description
    • Zofran injection, Novartis, 2 mg/mL, 20 mL vial, 1 count, NDC 00173-0442-00
    • Ondansetron injection, Apotex, 2 mg/mL, 2 mL vial, 25 count, NDC 60505-6130-05
    • Ondansetron injection, Athenex, 2 mg/mL, 2 mL vial, 25 count, NDC 70860-0776-02
    • Ondansetron injection, Athenex, 2 mg/mL, 20 mL vial, 1 count, NDC 70860-0777-20
    • Ondansetron injection, AuroMedics, 2 mg/mL, 2 mL vial, 25 count, NDC 55150-0125-02
    • Ondansetron injection, AuroMedics, 2 mg/mL, 20 mL vial, 1 count, NDC 55150-0126-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0103-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL vial, 25 count, NDC 63323-0373-02
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 1 count, NDC 63323-0374-20
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 10 count, NDC 23155-0547-41
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 25 count, NDC 23155-0547-42
    • Ondansetron injection, Heritage, 2 mg/mL, 20 mL vial, 1 count, NDC 23155-0549-31
    • Ondansetron injection, Mylan Institutional, 2 mg/mL, 2 mL vial, 25 count, NDC 67457-0441-20
    • Ondansetron injection, Mylan Institutional, 2 mg/mL, 20 mL vial, 1 count, NDC 67457-0440-20
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL iSecure syringe, 10 count, NDC 00409-1120-12
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL vial, 25 count, NDC 00409-4755-03
    • Ondansetron injection, Pfizer, 2 mg/mL, 20 mL vial, 1 count, NDC 00409-4759-01
    • Ondansetron injection, Sagent, 2 mg/mL, 2 mL vial, 25 count, NDC 25021-0777-02
    • Ondansetron injection, West-Ward, 2 mg/mL, 2 mL vial, 25 count, NDC 00641-6078-25
    • Ondansetron injection, West-Ward, 2 mg/mL, 20 mL vial, 1 count, NDC 00143-9890-01
    • Ondansetron injection, West-Ward, 2 mg/mL, 20 mL vial, 1 count, NDC 00641-6079-01
Reason for the Shortage
    • Apotex did not provide a reason for the shortage.
    • Athenex has ondansetron injection on shortage due to increased demand.
    • AuroMedics did not provide a reason for the shortage.
    • Fresenius Kabi has ondansetron injection available.
    • Heritage has ondansetron on shortage due to increased demand.
    • Mylan Institutional did not provide a reason for the shortage.
    • Pfizer has ondansetron injection on shortage due to manufacturing delays.
    • Sagent has ondansetron injection on shortage due to manufacturing delays.
    • West-Ward did not provide a reason for the shortage.
    • Novartis discontinued Zofran 20 mL vials in May 2018.
Available Products
    • Ondansetron injection, Sagent, 2 mg/mL, 20 mL vial, 1 count, NDC 25021-0782-20

Estimated Resupply Dates

    • Apotex has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of early-July 2018.
    • Athenex has ondansetron 2 mg/mL 2 mL and 20 mL vials on back order and the company estimates release dates of mid-June to early-July 2018.
    • AuroMedics has ondansetron 2 mg/mL 2 mL and 20 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Fresenius Kabi has ondansetron 2 mg/mL 2 mL and 20 mL vials on back order and the company cannot estimate release dates. The 2 mg/mL 2 mL prefilled syringes are on back order and the company estimates a release date of mid-September 2018.
    • Heritage has all ondansetron presentations on allocation.
    • Mylan Institutional has ondansetron 2 mg/mL 2 mL and 20 mL vials on back order and the company estimates release dates of late-June 2018.
    • Pfizer has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of June 2018. The 2 mg/mL 20 mL vials are on back order and the company estimates a release date of October 2018. The 2 mg/mL 2 mL iSecure syringes are on back order and the company estimates a release date of 2019.
    • Sagent has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of July 2018.
    • West-Ward has ondansetron 2 mg/mL 2 mL vials on allocation. The 2 mg/mL 20 mL vials are on back order and the company estimates a release date of early-July to early-August 2018.

Updated

Updated June 6, 2018 by Anthony Trovato, Pharmacy Resident. Created March 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide